Daxor Corp
SEC CIK 27367 · EDXR · last insider filing 2026-06-25
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Feldschuh Michael Richard | Director · President & CEO | filed 2013–2026 |
| Feuer Edward | Director | filed 2018–2026 |
| Feldschuh Jonathan Adam | Director · Chief Scientific Officer | filed 2017–2026 |
| Cremisi Henry D. | Director | filed 2020–2026 |
| Goudie Joy S. | Director | filed 2020–2026 |
| Desrosiers Caleb | Director | filed 2022–2026 |
| Lombard James A | Director | filed 2020–2023 |
| Wolpoff Martin S | Director | filed 2008–2020 |
| Saxe Bernhard | Director | filed 2014–2020 |
| Feldschuh Joseph | Director · President and CEO | filed 2006–2018 |
| Willens Robert | Director | filed 2006–2013 |
| Hudson Philip Nordan | Director | filed 2006–2012 |
| Moussa Robert G | Director | filed 2006–2006 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Michel Robert J | Chief Financial Officer | filed 2018–2026 |
| Jefferies John | Chief Medical Officer | filed 2025–2026 |
| Thompson Soren | Vice President | filed 2017–2018 |
| Meegan Diane Marie | Corporate Secretary | filed 2015–2015 |
| Engstrom Everis | Vice President | filed 2008–2008 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.